Literature DB >> 11943168

Expression of Fab fragment of catalytic antibody 6D9 in an Escherichia coli in vitro coupled transcription/translation system.

XiuPing Jiang1, Yuji Ookubo, Ikuo Fujii, Hideo Nakano, Tsuneo Yamane.   

Abstract

The heavy chain (Hc) and light chain (Lc) genes of the Fab fragment of a catalytic antibody 6D9 were simultaneously expressed in an Escherichia coli in vitro transcription/translation system without a reducing agent. The intermolecular disulfide bond between the Hc and Lc was found formed, suggesting a correct formation of the Fab fragment in the in vitro system. In enzyme-linked immunosorbent assay, the Fab fragment synthesized in vitro exhibited an antigen-binding activity. Addition of reduced glutathione, oxidized glutathione, protein disulfide-isomerase and molecular chaperones, GroEL and GroES, increased the solubility and the antigen-binding activity of the Fab fragment greatly. The in vitro synthesized Fab was purified by means of a hexa-histidine tag attached to the C-terminus of the Hc. Catalytic assay of the purified Fab fragment showed that the His-tagged Fab fragment synthesized in vitro had a catalytic activity comparable to that produced in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943168     DOI: 10.1016/s0014-5793(02)02383-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.

Authors:  R Zichel; A Mimran; A Keren; A Barnea; I Steinberger-Levy; D Marcus; A Turgeman; S Reuveny
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

2.  Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system.

Authors:  Gang Yin; Eudean D Garces; Junhao Yang; Juan Zhang; Cuong Tran; Alexander R Steiner; Christine Roos; Sunil Bajad; Susan Hudak; Kalyani Penta; James Zawada; Sonia Pollitt; Christopher J Murray
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

3.  Cell-free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments.

Authors:  Marlitt Stech; Michael Hust; Corina Schulze; Stefan Dübel; Stefan Kubick
Journal:  Eng Life Sci       Date:  2014-07-15       Impact factor: 2.678

4.  Perspective: Solidifying the impact of cell-free synthetic biology through lyophilization.

Authors:  Keith Pardee
Journal:  Biochem Eng J       Date:  2018-10-15       Impact factor: 3.978

5.  Constructive approach for synthesis of a functional IgG using a reconstituted cell-free protein synthesis system.

Authors:  Satoshi Murakami; Rena Matsumoto; Takashi Kanamori
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

Review 6.  Synthetic Biology Goes Cell-Free.

Authors:  Aidan Tinafar; Katariina Jaenes; Keith Pardee
Journal:  BMC Biol       Date:  2019-08-08       Impact factor: 7.431

Review 7.  Escherichia coli Extract-Based Cell-Free Expression System as an Alternative for Difficult-to-Obtain Protein Biosynthesis.

Authors:  Sviatlana Smolskaya; Yulia A Logashina; Yaroslav A Andreev
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

8.  Cell-Free Protein Synthesis for the Screening of Novel Azoreductases and Their Preferred Electron Donor.

Authors:  Jascha Rolf; Anna Christina Reyes Ngo; Stephan Lütz; Dirk Tischler; Katrin Rosenthal
Journal:  Chembiochem       Date:  2022-06-16       Impact factor: 3.461

9.  A continuous-exchange cell-free protein synthesis system based on extracts from cultured insect cells.

Authors:  Marlitt Stech; Robert B Quast; Rita Sachse; Corina Schulze; Doreen A Wüstenhagen; Stefan Kubick
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

Review 10.  Cell-Free Protein Synthesis: Pros and Cons of Prokaryotic and Eukaryotic Systems.

Authors:  Anne Zemella; Lena Thoring; Christian Hoffmeister; Stefan Kubick
Journal:  Chembiochem       Date:  2015-10-19       Impact factor: 3.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.